Stock listing
Ryvu Therapeutics Sa
Selected listing: 9Y4 · FWB · EUR · DE
Ryvu Therapeutics Sa (Frankfurt:9Y4), Health Technology. Latest release May 16, 2024: Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate…
- Ticker
- Frankfurt:9Y4
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Ryvu Therapeutics Sa
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
May 16, 2024
Ryvu Therapeutics - Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes
October 23, 2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Solid Tumors and AML/HR-MDS, and Presents the Updated Development Plan for RVU120
October 23, 2023
Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million
December 22, 2022
Ryvu Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 24, 2022
Research Ryvu Therapeutics Sa
Ryvu Therapeutics Sa company profile
View the public company page for Ryvu Therapeutics Sa on 6ix.
Ryvu Therapeutics Sa news
Read company news and market updates connected to Ryvu Therapeutics Sa.
Ryvu Therapeutics Sa investor events
Find investor webinars, events, and replay context for Ryvu Therapeutics Sa.
Alternate listings
RVU:GPW
PL · PLN
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.
A1JUH2:LS
DE · EUR
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.
A1JUH2:LSX
DE · EUR
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.
0RKT:LSE
GB · PLN
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.
9Y4:SWB
DE · EUR
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.
9Y4:DUS
DE · EUR
Alternate listing for Ryvu Therapeutics Sa; the primary context on this page is 9Y4:FWB.